Corcept Therapeutics Incorporated (LON:0I3Q)
London · Delayed Price · Currency is GBP · Price in USD 39.65
-0.13 (-0.32%)
Feb 12, 2026, 5:10 PM GMT
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of 3.15 billion as of February 12, 2026. Its market cap has decreased by -38.41% in one year.
Market Cap
3.15B
Enterprise Value
2.77B
Revenue
551.39M
Ranking
n/a
PE Ratio
40.43
Stock Price
39.65
Market Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from 154.68M to 3.15B, an increase of 1,935.00%. That is a compound annual growth rate of 14.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.15B | 15.74% |
| Dec 31, 2025 | 2.72B | -35.51% |
| Dec 31, 2024 | 4.22B | 60.44% |
| Dec 29, 2023 | 2.63B | 44.86% |
| Dec 30, 2022 | 1.81B | 17.14% |
| Dec 31, 2021 | 1.55B | -30.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 88.21B |
| Haleon | 34.95B |
| Smith & Nephew | 10.77B |
| Convatec Group | 4.40B |
| Hikma Pharmaceuticals | 3.41B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |